Universidad de Granada

Quick facts

Marketed products

• GTO® · Other
• Hydroxypropyl Guar
• trazodone, pregabalin · Psychiatry/Neurology (Anxiety, Pain Management)
  This is a fixed-dose combination of trazodone (a serotonin antagonist and reuptake inhibitor) and pregabalin (a gabapentinoid that modulates calcium channels) designed to treat anxiety and pain-related conditions.

Phase 1 pipeline

• cephalosporin with or without erythromycin
• Medical standard treatment
• osteoimplant · Other

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Universidad de Granada portfolio CI brief
• Universidad de Granada pipeline updates RSS

Frequently asked questions about Universidad de Granada

Related

• GTO® · Other
• Hydroxypropyl Guar
• trazodone, pregabalin · Psychiatry/Neurology (Anxiety, Pain Management)
• Sector hub: All tracked pharma companies